Covigilant Research, LLC

Committed To Working Together

Pa. coronavirus update: Synthetic antibodies in development as new COVID-19 treatment

December 16, 2020 December 16, 2020

Updated: 5:30 p.m.. Pennsylvania reported 9,556 new cases of COVID-19 Tuesday, for a statewide case total of 509,320 since the start of the …Read More

FluroTech Partners With Toolbox Medical Innovations for Clinical Trial of Mass-Scale COVID-19 Testing Platform
on March 4, 2021
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover ...
Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine
on March 4, 2021
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Eastern Michigan University Clinical Research Administration Program Ranked Third Best in the U.S., Top Program in Michigan, According to New Rankings
on March 4, 2021
The Clinical Research Administration graduate program at Eastern Michigan University is the third highest ranked program in the United States and number one in Michigan according to ...
United States Depression Drugs Market Report 2021-2026: Dosage, Formulation, Patent, Pricing Insight by Drug Class - ResearchAndMarkets.com
on March 3, 2021
The “US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The complete research report is divided into several sections ...
Arena Pharmaceuticals Reports Topline Results from Phase 2b CAPTIVATE Clinical Trial
on March 2, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced topline results from the randomized, double-blind, placebo-controlled Phase 2b CAPTIVATE clinical trial evaluating three doses of olorinab, a ...
Global Clinical Trial Market 2020 Status and Outlook, Industry Growth Rate, Opportunities and Challenges to 2025
on March 2, 2021
This study document namely Global Clinical Trial Market Growth (Status and Outlook) 2020-2025 begins with an overview of the market and presents it throughout its development. The report effectively ...
Aileron Therapeutics Announces Enrollment Expansion for Upcoming Phase 1b Clinical Trial of ...
on March 2, 2021
Placebo-controlled trial anticipated to enroll 60 patients with advanced p53-mutated NSCLC undergoing treatment with first-line carboplatin plus pemetrexed ---- Trial anticipate ...
United States Proton Therapy Market Size to Witness Huge Growth by 2025
on March 2, 2021
Selbyville, Delaware According to the latest research report titled 'United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, ...
Medidata Thought Leaders Discuss the Future of Clinical Trials at 2021 SCOPE Annual Meeting
on March 1, 2021
Medidata experts are presenting on clinical trial planning, management, and operations at the Summit for Clinical Ops Executives (SCOPE) meeting.
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody
on February 28, 2021
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Velocity Clinical Research, backed by NaviMed, seeks buyer
on February 25, 2021
The clinical site organization has recruited nearly 10,000 patients for covid-19 studies in total – accelerating business growth tremendously over the last several months.
Preventative shot for Lyme disease, developed at UMass Medical School, enters clinical trial
on February 23, 2021
Lyme PrEP, a seasonal shot to prevent Lyme disease developed by MassBiologics at UMass Medical School, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment.